What's New on the FDA Drugs Site
July 18, 2017
- Current Biomarker Qualification Submissions (updated)
- Development of New Tuberculosis Drug Regimens-Scientific and Clinical Design Considerations(updated)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Nerlynx (neratinib), a new treatment to reduce the risk of breast cancer returning
- FDA approves Vosevi for Hepatitis C
- FDA Drug Shortages
- Dexrazoxane Injection (Updated - Currently in Shortage)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario